HIMS Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of August 25, 2025 Deadline in Securities Fraud Class Action Lawsuit Against Hims & Hers Health, Inc. (HIMS)

Core Viewpoint - Securities class action lawsuits have been filed against Hims & Hers Health, Inc. for allegedly making false and misleading statements regarding the company's business practices and safety concerns related to its products [1][2]. Allegations Against Hims & Hers - The complaints allege that Hims & Hers engaged in deceptive promotion and selling of illegitimate versions of Wegovy, which posed risks to patient safety [2]. - It is claimed that there was a substantial risk of termination of Hims & Hers' collaboration with Novo Nordisk due to these practices [2]. - The positive statements made by the company regarding its business and prospects were allegedly materially misleading and lacked a reasonable basis [2]. Lead Plaintiff Process - Investors in Hims & Hers have until August 25, 2025, to seek appointment as a lead plaintiff representative of the class [3]. - The lead plaintiff will act on behalf of all class members and select counsel to represent the class in the litigation [3]. Firm Background - Kessler Topaz Meltzer & Check, LLP has a reputation for prosecuting class actions and has recovered billions for victims of corporate misconduct [4].